Antineoplaston Therapy in Treating Patients With Stage IV Cancer of the Cervix and/or Vulva

Summary

Current therapies for Stage IV Cancer of the Cervix and/or Vulva provide very limited benefit to the patient. The anti-cancer properties of Antineoplaston therapy suggest that it may prove beneficial in the treatment of Stage IV Cancer of the Cervix and/or Vulva. PURPOSE: This study is being performed to determine the effects (good and bad) that Antineoplaston therapy has on patients with Stage IV Cancer of the Cervix and/or Vulva.

Timeline

Start

1996-06-03

Primary completion

1998-01-22

Completion

1998-01-22

Drugs

Indications